WO2000000244A1 - Temperature controlling device for aerosol drug delivery - Google Patents
Temperature controlling device for aerosol drug delivery Download PDFInfo
- Publication number
- WO2000000244A1 WO2000000244A1 PCT/US1999/014762 US9914762W WO0000244A1 WO 2000000244 A1 WO2000000244 A1 WO 2000000244A1 US 9914762 W US9914762 W US 9914762W WO 0000244 A1 WO0000244 A1 WO 0000244A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- air
- aerosol
- heating element
- drug
- temperature controlling
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/0045—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
- A61M11/001—Particle size control
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/0045—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
- A61M15/0046—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier
- A61M15/0051—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier the dosages being arranged on a tape, e.g. strips
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/10—Preparation of respiratory gases or vapours
- A61M16/1075—Preparation of respiratory gases or vapours by influencing the temperature
- A61M16/108—Preparation of respiratory gases or vapours by influencing the temperature before being humidified or mixed with a beneficial agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/10—Preparation of respiratory gases or vapours
- A61M16/1075—Preparation of respiratory gases or vapours by influencing the temperature
- A61M16/1085—Preparation of respiratory gases or vapours by influencing the temperature after being humidified or mixed with a beneficial agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/10—Preparation of respiratory gases or vapours
- A61M16/1075—Preparation of respiratory gases or vapours by influencing the temperature
- A61M16/1095—Preparation of respiratory gases or vapours by influencing the temperature in the connecting tubes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/10—Preparation of respiratory gases or vapours
- A61M16/14—Preparation of respiratory gases or vapours by mixing different fluids, one of them being in a liquid phase
- A61M16/142—Preparation of respiratory gases or vapours by mixing different fluids, one of them being in a liquid phase with semi-permeable walls separating the liquid from the respiratory gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/10—Preparation of respiratory gases or vapours
- A61M16/14—Preparation of respiratory gases or vapours by mixing different fluids, one of them being in a liquid phase
- A61M16/16—Devices to humidify the respiration air
- A61M16/161—Devices to humidify the respiration air with means for measuring the humidity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/10—Preparation of respiratory gases or vapours
- A61M16/1075—Preparation of respiratory gases or vapours by influencing the temperature
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/10—Preparation of respiratory gases or vapours
- A61M16/14—Preparation of respiratory gases or vapours by mixing different fluids, one of them being in a liquid phase
- A61M16/16—Devices to humidify the respiration air
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/0003—Accessories therefor, e.g. sensors, vibrators, negative pressure
- A61M2016/0015—Accessories therefor, e.g. sensors, vibrators, negative pressure inhalation detectors
- A61M2016/0018—Accessories therefor, e.g. sensors, vibrators, negative pressure inhalation detectors electrical
- A61M2016/0021—Accessories therefor, e.g. sensors, vibrators, negative pressure inhalation detectors electrical with a proportional output signal, e.g. from a thermistor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/0003—Accessories therefor, e.g. sensors, vibrators, negative pressure
- A61M2016/003—Accessories therefor, e.g. sensors, vibrators, negative pressure with a flowmeter
- A61M2016/0033—Accessories therefor, e.g. sensors, vibrators, negative pressure with a flowmeter electrical
- A61M2016/0039—Accessories therefor, e.g. sensors, vibrators, negative pressure with a flowmeter electrical in the inspiratory circuit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/06—Solids
- A61M2202/062—Desiccants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3368—Temperature
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
- A61M2205/52—General characteristics of the apparatus with microprocessors or computers with memories providing a history of measured variating parameters of apparatus or patient
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU48462/99A AU759358B2 (en) | 1998-06-30 | 1999-06-29 | Temperature controlling device for aerosol drug delivery |
EP99932072A EP1091778A4 (en) | 1998-06-30 | 1999-06-29 | Temperature controlling device for aerosol drug delivery |
JP2000556828A JP2002519120A (en) | 1998-06-30 | 1999-06-29 | Temperature control device for aerosol drug delivery |
CA002335553A CA2335553A1 (en) | 1998-06-30 | 1999-06-29 | Temperature controlling device for aerosol drug delivery |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/107,306 | 1998-06-30 | ||
US09/107,306 US6131570A (en) | 1998-06-30 | 1998-06-30 | Temperature controlling device for aerosol drug delivery |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2000000244A1 true WO2000000244A1 (en) | 2000-01-06 |
Family
ID=22315962
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1999/014762 WO2000000244A1 (en) | 1998-06-30 | 1999-06-29 | Temperature controlling device for aerosol drug delivery |
Country Status (6)
Country | Link |
---|---|
US (4) | US6131570A (en) |
EP (1) | EP1091778A4 (en) |
JP (1) | JP2002519120A (en) |
AU (1) | AU759358B2 (en) |
CA (1) | CA2335553A1 (en) |
WO (1) | WO2000000244A1 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1882487A1 (en) | 2006-07-24 | 2008-01-30 | Canon Kabushiki Kaisha | Inhaler |
US8955512B2 (en) | 2001-06-05 | 2015-02-17 | Alexza Pharmaceuticals, Inc. | Method of forming an aerosol for inhalation delivery |
US8991387B2 (en) | 2003-05-21 | 2015-03-31 | Alexza Pharmaceuticals, Inc. | Self-contained heating unit and drug-supply unit employing same |
US9211382B2 (en) | 2001-05-24 | 2015-12-15 | Alexza Pharmaceuticals, Inc. | Drug condensation aerosols and kits |
US11642473B2 (en) | 2007-03-09 | 2023-05-09 | Alexza Pharmaceuticals, Inc. | Heating unit for use in a drug delivery device |
Families Citing this family (359)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5888477A (en) * | 1993-01-29 | 1999-03-30 | Aradigm Corporation | Use of monomeric insulin as a means for improving the bioavailability of inhaled insulin |
US8022095B2 (en) * | 1996-08-16 | 2011-09-20 | Pozen, Inc. | Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs |
US6131570A (en) * | 1998-06-30 | 2000-10-17 | Aradigm Corporation | Temperature controlling device for aerosol drug delivery |
US6694975B2 (en) * | 1996-11-21 | 2004-02-24 | Aradigm Corporation | Temperature controlling device for aerosol drug delivery |
US6234167B1 (en) | 1998-10-14 | 2001-05-22 | Chrysalis Technologies, Incorporated | Aerosol generator and methods of making and using an aerosol generator |
US6196218B1 (en) * | 1999-02-24 | 2001-03-06 | Ponwell Enterprises Ltd | Piezo inhaler |
US7897140B2 (en) | 1999-12-23 | 2011-03-01 | Health Research, Inc. | Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents |
SE517225C2 (en) * | 2000-09-21 | 2002-05-14 | Microdrug Ag | Optimization of an electrostatically dosed dry powder inhaler |
US20040050385A1 (en) * | 2000-10-20 | 2004-03-18 | Bonney Stanley George | Inhaler |
CA2431205C (en) * | 2000-12-05 | 2005-08-23 | Alexander Macgregor | Hydrostatic delivery system for controlled delivery of agent |
US7077130B2 (en) * | 2000-12-22 | 2006-07-18 | Chrysalis Technologies Incorporated | Disposable inhaler system |
US6491233B2 (en) | 2000-12-22 | 2002-12-10 | Chrysalis Technologies Incorporated | Vapor driven aerosol generator and method of use thereof |
US6501052B2 (en) | 2000-12-22 | 2002-12-31 | Chrysalis Technologies Incorporated | Aerosol generator having multiple heating zones and methods of use thereof |
US6799572B2 (en) | 2000-12-22 | 2004-10-05 | Chrysalis Technologies Incorporated | Disposable aerosol generator system and methods for administering the aerosol |
US6701921B2 (en) | 2000-12-22 | 2004-03-09 | Chrysalis Technologies Incorporated | Aerosol generator having heater in multilayered composite and method of use thereof |
US6681998B2 (en) | 2000-12-22 | 2004-01-27 | Chrysalis Technologies Incorporated | Aerosol generator having inductive heater and method of use thereof |
US6904912B2 (en) * | 2001-01-31 | 2005-06-14 | The United States Of America As Represented By The Secretary Of The Army | Automated inhalation toxicology exposure system |
WO2002092147A2 (en) * | 2001-05-11 | 2002-11-21 | Aradigm Corporation | Optimization of the molecular properties and formulation of proteins delivered by inhalation |
US6805853B2 (en) * | 2001-11-09 | 2004-10-19 | Alexza Molecular Delivery Corporation | Delivery of diazepam through an inhalation route |
US7645442B2 (en) | 2001-05-24 | 2010-01-12 | Alexza Pharmaceuticals, Inc. | Rapid-heating drug delivery article and method of use |
US7498019B2 (en) | 2001-05-24 | 2009-03-03 | Alexza Pharmaceuticals, Inc. | Delivery of compounds for the treatment of headache through an inhalation route |
JP2005503425A (en) | 2001-05-24 | 2005-02-03 | アレックザ モレキュラー デリヴァリー コーポレイション | Delivery of drug ester by the prescribed inhalation route |
US7458374B2 (en) | 2002-05-13 | 2008-12-02 | Alexza Pharmaceuticals, Inc. | Method and apparatus for vaporizing a compound |
EP1392258B1 (en) | 2001-05-24 | 2008-11-26 | Alexza Pharmaceuticals, Inc. | Delivery of alprazolam, estazolam, midazolam or triazolam through an inhalation route |
US6759029B2 (en) * | 2001-05-24 | 2004-07-06 | Alexza Molecular Delivery Corporation | Delivery of rizatriptan and zolmitriptan through an inhalation route |
US6568390B2 (en) | 2001-09-21 | 2003-05-27 | Chrysalis Technologies Incorporated | Dual capillary fluid vaporizing device |
US6640050B2 (en) | 2001-09-21 | 2003-10-28 | Chrysalis Technologies Incorporated | Fluid vaporizing device having controlled temperature profile heater/capillary tube |
US20050065118A1 (en) * | 2001-10-16 | 2005-03-24 | Jing Wang | Organosulfur inhibitors of tyrosine phosphatases |
ATE298600T1 (en) * | 2001-10-18 | 2005-07-15 | Pari Gmbh | INHALATION THERAPY DEVICE |
US6804458B2 (en) | 2001-12-06 | 2004-10-12 | Chrysalis Technologies Incorporated | Aerosol generator having heater arranged to vaporize fluid in fluid passage between bonded layers of laminate |
US6681769B2 (en) | 2001-12-06 | 2004-01-27 | Crysalis Technologies Incorporated | Aerosol generator having a multiple path heater arrangement and method of use thereof |
CA2466525C (en) * | 2001-12-07 | 2011-05-17 | Eiffel Technologies Limited | Synthesis of small particles |
US6701922B2 (en) | 2001-12-20 | 2004-03-09 | Chrysalis Technologies Incorporated | Mouthpiece entrainment airflow control for aerosol generators |
US6705316B2 (en) | 2002-03-11 | 2004-03-16 | Battelle Pulmonary Therapeutics, Inc. | Pulmonary dosing system and method |
US6889690B2 (en) * | 2002-05-10 | 2005-05-10 | Oriel Therapeutics, Inc. | Dry powder inhalers, related blister devices, and associated methods of dispensing dry powder substances and fabricating blister packages |
US7677411B2 (en) | 2002-05-10 | 2010-03-16 | Oriel Therapeutics, Inc. | Apparatus, systems and related methods for processing, dispensing and/or evaluatingl dry powders |
WO2003094900A1 (en) | 2002-05-13 | 2003-11-20 | Alexza Molecular Delivery Corporation | Delivery of drug amines through an inhalation route |
US6830744B2 (en) | 2002-05-31 | 2004-12-14 | Aradigm Corporation | Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b |
US8829198B2 (en) * | 2007-10-31 | 2014-09-09 | Proteotech Inc | Compounds, compositions and methods for the treatment of beta-amyloid diseases and synucleinopathies |
US20050232899A1 (en) * | 2002-05-31 | 2005-10-20 | Aradigm Corporation | Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b |
EP1517684B1 (en) | 2002-06-27 | 2009-07-22 | Health Research, Inc. | Fluorinated chlorin and bacteriochlorin photosensitizers for photodynamic therapy |
WO2004002395A2 (en) * | 2002-06-27 | 2004-01-08 | Oriel Therapeutics, Inc. | Apparatus, systems and related methods for processing, dispensing and/or evaluating non-pharmaceutical dry powders |
WO2004022128A2 (en) * | 2002-09-06 | 2004-03-18 | Chrysalis Technologies Incorporated | Liquid aerosol formulations and aerosol generating devices and methods for generating aerosols |
US20040055595A1 (en) * | 2002-09-19 | 2004-03-25 | Noymer Peter D. | Aerosol drug delivery system employing formulation pre-heating |
US6904907B2 (en) * | 2002-11-19 | 2005-06-14 | Honeywell International Inc. | Indirect flow measurement through a breath-operated inhaler |
US20040105818A1 (en) | 2002-11-26 | 2004-06-03 | Alexza Molecular Delivery Corporation | Diuretic aerosols and methods of making and using them |
US7550133B2 (en) | 2002-11-26 | 2009-06-23 | Alexza Pharmaceuticals, Inc. | Respiratory drug condensation aerosols and methods of making and using them |
AU2003294470B2 (en) | 2002-11-26 | 2009-09-17 | Alexza Pharmaceuticals, Inc. | Use of loxapine and amoxapine for the manufacture of a medicament for the treatment of pain |
US7913688B2 (en) | 2002-11-27 | 2011-03-29 | Alexza Pharmaceuticals, Inc. | Inhalation device for producing a drug aerosol |
WO2004066705A2 (en) * | 2003-01-24 | 2004-08-12 | University Of Virginia Patent Foundation | Non-invasive drug self-administration system for animals |
US7726303B2 (en) * | 2003-02-25 | 2010-06-01 | Hewlett-Packard Development Company, L.P. | Controlled medicament ejection |
WO2004099162A1 (en) * | 2003-04-30 | 2004-11-18 | Ricerca Biosciences, Llc. | Polycyclic diazodioxide-based bcl-2 protein antagonist |
US20040242886A1 (en) * | 2003-04-30 | 2004-12-02 | Sandeep Gupta | Monocyclic diazodioxide based Bcl-2 protein antagonists related applications |
BRPI0410348A (en) * | 2003-05-14 | 2006-05-30 | Torreypines Therapeutics Inc | compounds and uses thereof in amyloid-beta modulation |
US7883031B2 (en) | 2003-05-20 | 2011-02-08 | James F. Collins, Jr. | Ophthalmic drug delivery system |
US8545463B2 (en) | 2003-05-20 | 2013-10-01 | Optimyst Systems Inc. | Ophthalmic fluid reservoir assembly for use with an ophthalmic fluid delivery device |
US20100331380A1 (en) * | 2009-06-29 | 2010-12-30 | Esposito Luke A | Compounds, Compositions, and Methods for the Treatment of Beta-Amyloid Diseases and Synucleinopathies |
US8916598B2 (en) | 2003-05-30 | 2014-12-23 | Proteotech Inc | Compounds, compositions, and methods for the treatment of β-amyloid diseases and synucleinopathies |
US7377277B2 (en) * | 2003-10-27 | 2008-05-27 | Oriel Therapeutics, Inc. | Blister packages with frames and associated methods of fabricating dry powder drug containment systems |
US7451761B2 (en) * | 2003-10-27 | 2008-11-18 | Oriel Therapeutics, Inc. | Dry powder inhalers, related blister package indexing and opening mechanisms, and associated methods of dispensing dry powder substances |
WO2005090370A1 (en) * | 2004-02-05 | 2005-09-29 | The Regents Of The University Of California | Pharmacologically active agents containing esterified phosphonates and methods for use thereof |
WO2005112913A1 (en) | 2004-05-20 | 2005-12-01 | The Scripps Research Institute | Transthyretin stabilization |
US7402777B2 (en) * | 2004-05-20 | 2008-07-22 | Alexza Pharmaceuticals, Inc. | Stable initiator compositions and igniters |
US7540286B2 (en) | 2004-06-03 | 2009-06-02 | Alexza Pharmaceuticals, Inc. | Multiple dose condensation aerosol devices and methods of forming condensation aerosols |
SE530006C2 (en) * | 2004-06-18 | 2008-02-05 | Mederio Ag | Inhaler using tub |
US20060135773A1 (en) * | 2004-06-17 | 2006-06-22 | Semple Joseph E | Trisubstituted nitrogen modulators of tyrosine phosphatases |
WO2006017124A2 (en) * | 2004-07-09 | 2006-02-16 | Cengent Therapeutics, Inc. | Oxygen/nitrogen heterocycle inhibitors of tyrosine phosphatases |
EP1841749A1 (en) * | 2004-09-02 | 2007-10-10 | Metabasis Therapeutics, Inc. | Derivatives of thiazole and thiadiazole inhibitors of tyrosine phosphatases |
NZ588431A (en) | 2004-09-17 | 2012-02-24 | Whitehead Biomedical Inst | Using Benzimidazole or Indole compounds with a 1,2-diazole group to Inhibit Alpha-Synuclein Toxicity |
US20060067889A1 (en) * | 2004-09-27 | 2006-03-30 | Light Sciences Corporation | Singlet oxygen photosensitizers activated by target binding enhancing the selectivity of targeted PDT agents |
US7180039B2 (en) * | 2004-10-29 | 2007-02-20 | Osram Sylvania Inc. | Heater with burnout protection |
ES2645340T3 (en) | 2004-11-16 | 2017-12-05 | Uptake Medical Technology Inc. | Lung treatment device |
US7814901B2 (en) * | 2005-03-09 | 2010-10-19 | Ric Investments, Llc | Nebulizing drug delivery device with increased flow rate |
US8222257B2 (en) | 2005-04-01 | 2012-07-17 | The Regents Of The University Of California | Phosphono-pent-2-en-1-yl nucleosides and analogs |
US20090156545A1 (en) * | 2005-04-01 | 2009-06-18 | Hostetler Karl Y | Substituted Phosphate Esters of Nucleoside Phosphonates |
JP4689340B2 (en) * | 2005-05-02 | 2011-05-25 | キヤノン株式会社 | Liquid pharmaceutical composition for discharge |
WO2007002109A2 (en) * | 2005-06-20 | 2007-01-04 | The Regents Of The University Of California | Multidentate pyrone-derived chelators for medicinal imaging and chelation |
WO2008051197A2 (en) * | 2005-09-20 | 2008-05-02 | Mayo Foundation For Medical Education And Research | Small-molecule botulinum toxin inhibitors |
FR2891435B1 (en) * | 2005-09-23 | 2007-11-09 | Bull Sa Sa | HOLDING SYSTEM IN POSITION OF A THREE-PART ASSEMBLY PROVIDING A PREDETERMINAL COMPRESSION EFFORT ON THE INTERMEDIATE PART |
US7765792B2 (en) | 2005-10-21 | 2010-08-03 | Honeywell International Inc. | System for particulate matter sensor signal processing |
DE102005057685A1 (en) * | 2005-12-01 | 2007-06-06 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Inhaler and storage for a dry drug formulation and methods and use thereof |
US8820662B2 (en) | 2005-12-22 | 2014-09-02 | Donovan B. Yeates | Nozzle and nozzle holder for an aerosol generator |
WO2007076160A2 (en) * | 2005-12-28 | 2007-07-05 | Acidophil Llc | C-10 carbamates of taxanes |
US7494344B2 (en) | 2005-12-29 | 2009-02-24 | Molex Incorporated | Heating element connector assembly with press-fit terminals |
PL2383271T3 (en) * | 2006-03-13 | 2013-12-31 | Kyorin Seiyaku Kk | Aminoquinolones as GSK-3 Inhibitors |
BRPI0709699A2 (en) * | 2006-03-29 | 2011-07-26 | Foldrx Pharmaceuticals Inc | inhibition of alpha synuclein toxicity |
EP2064243A2 (en) | 2006-08-28 | 2009-06-03 | Kyowa Hakko Kirin Co., Ltd. | Antagonistic human light-specific human monoclonal antibodies |
AU2007297597B2 (en) | 2006-09-21 | 2013-02-21 | Kyorin Pharmaceuticals Co., Ltd. | Serine hydrolase inhibitors |
JP2010507585A (en) | 2006-10-19 | 2010-03-11 | オースペックス・ファーマシューティカルズ・インコーポレイテッド | Substituted indole |
US20080138397A1 (en) * | 2006-10-24 | 2008-06-12 | Aradigm Corporation | Processes for taste-masking of inhaled formulations |
WO2008057604A2 (en) * | 2006-11-08 | 2008-05-15 | The Regents Of The University Of California | Small molecule therapeutics, syntheses of analogues and derivatives and methods of use |
US7993323B2 (en) * | 2006-11-13 | 2011-08-09 | Uptake Medical Corp. | High pressure and high temperature vapor catheters and systems |
US20080146605A1 (en) | 2006-12-19 | 2008-06-19 | Auspex Pharmaceuticals, Inc. | Preparation and utility of ccr5 inhibitors |
WO2008079371A1 (en) * | 2006-12-22 | 2008-07-03 | Encysive Pharmaceuticals, Inc. | Modulators of c3a receptor and methods of use thereof |
WO2008080170A1 (en) * | 2006-12-22 | 2008-07-03 | Alexza Pharmaceuticals, Inc. | Mixed drug aerosol compositiions |
US7513781B2 (en) | 2006-12-27 | 2009-04-07 | Molex Incorporated | Heating element connector assembly with insert molded strips |
PL2144604T3 (en) * | 2007-02-28 | 2012-02-29 | Conatus Pharmaceuticals Inc | Methods for the treatment of chronic viral hepatitis C using RO 113-0830 |
WO2008106167A1 (en) * | 2007-02-28 | 2008-09-04 | Conatus Pharmaceuticals, Inc. | Combination therapy comprising matrix metalloproteinase inhibitors and caspase inhibitors for the treatment of liver diseases |
EP3103790B1 (en) | 2007-03-15 | 2018-05-09 | Auspex Pharmaceuticals, Inc. | Substituted phenethylamine with serotoninergic and/or norepinephrinergic activity |
US7892776B2 (en) | 2007-05-04 | 2011-02-22 | The Regents Of The University Of California | Screening assay to identify modulators of protein kinase A |
WO2008144106A1 (en) * | 2007-05-16 | 2008-11-27 | Aradigm Corporation | Burst valve for aerosol device |
CN101801188A (en) * | 2007-07-12 | 2010-08-11 | 特拉加拉医药品公司 | Methods and compositions for the treatment of cancer, tumors, and tumor-related disorders |
AU2008299903B2 (en) * | 2007-09-11 | 2013-08-29 | Kyorin Pharmaceutical Co., Ltd | Cyanoaminoquinolones and tetrazoloaminoquinolones as GSK-3 inhibitors |
CN101855229A (en) | 2007-09-12 | 2010-10-06 | 埃迪威克斯生物科学公司 | Spirocyclic aminoquinolones as GSK-3 inhibitors |
US20090264421A1 (en) * | 2007-10-05 | 2009-10-22 | Bible Keith C | Methods and Compositions for Treating Cancer |
CA2706465A1 (en) | 2007-11-21 | 2009-05-28 | Pharmaxis Ltd. | Haloallylamine inhibitors of ssao/vap-1 and uses therefor |
WO2009111611A2 (en) * | 2008-03-05 | 2009-09-11 | Proteotech Inc. | Compounds, compositions and methods for the treatment of islet amyloid polypeptide (iapp) accumulation in diabetes |
US8201752B2 (en) * | 2008-03-10 | 2012-06-19 | Vapore, Inc. | Low energy vaporization of liquids: apparatus and methods |
MX2010010172A (en) | 2008-03-17 | 2010-11-25 | Ambit Biosciences Corp | Quinazoline derivatives as raf kinase modulators and methods of use thereof. |
US20120034157A1 (en) * | 2010-08-03 | 2012-02-09 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Artificial cells |
CN101658533A (en) * | 2008-08-29 | 2010-03-03 | 首都医科大学宣武医院 | Delivery of stem cells of antitumor medicament |
WO2010088450A2 (en) | 2009-01-30 | 2010-08-05 | Celladon Corporation | Methods for treating diseases associated with the modulation of serca |
US8568793B2 (en) | 2009-02-11 | 2013-10-29 | Hope Medical Enterprises, Inc. | Sodium nitrite-containing pharmaceutical compositions |
MY159327A (en) * | 2009-02-27 | 2016-12-25 | Ambit Biosciences Corp | Jak kinase modulating quinazoline derivatives and methods of use thereof |
US8193372B2 (en) | 2009-03-04 | 2012-06-05 | Idenix Pharmaceuticals, Inc. | Phosphothiophene and phosphothiazole HCV polymerase inhibitors |
BRPI1008974A2 (en) * | 2009-03-11 | 2017-06-06 | Kyorin Seiyaku Kk | compound, pharmaceutical composition, and method for treating, preventing or ameliorating a gsk-3 mediated disease |
JP2012520314A (en) | 2009-03-11 | 2012-09-06 | アムビト ビオスシエンセス コルポラチオン | Combination of indazolylaminopyrrolotriazine and taxane for cancer treatment |
JP5671001B2 (en) | 2009-03-26 | 2015-02-18 | パルマトリックス,インコーポレイテッド | Dry powder formulation and method for treating lung disease |
NZ595372A (en) | 2009-03-27 | 2013-11-29 | Vetdc Inc | Pyrimidinyl and 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy |
WO2010110686A1 (en) | 2009-03-27 | 2010-09-30 | Pathway Therapeutics Limited | Pyrimidinyl and 1,3,5 triazinyl benzimidazoles and their use in cancer therapy |
PE20150925A1 (en) | 2009-04-22 | 2015-06-14 | Axikin Pharmaceuticals Inc | CCR3 ANTAGONISTS OF ARYLSULFONAMIDE 2,5-DISUSTITUID |
PE20150759A1 (en) | 2009-04-22 | 2015-05-15 | Axikin Pharmaceuticals Inc | CCR3 ARYLSULFONAMIDE ANTAGONISTS |
DK2421829T3 (en) | 2009-04-22 | 2016-01-04 | Axikin Pharmaceuticals Inc | 2,5-disubstituted aryl sulfonamide CCR3 antagonists |
WO2011003870A2 (en) | 2009-07-06 | 2011-01-13 | Creabilis S.A. | Mini-pegylated corticosteroids, compositions including same, and methods of making and using same |
EP2451802A1 (en) | 2009-07-07 | 2012-05-16 | Pathway Therapeutics, Inc. | Pyrimidinyl and 1,3,5-triazinyl benzimidazoles and their use in cancer therapy |
JP5905387B2 (en) | 2009-07-08 | 2016-04-20 | ホープ メディカル エンタープライゼズ,インコーポレイテッド ディービーエー ホープ ファーマシュティカルズHope Medical Enterprises,Inc.Dba Hope Pharmaceuticals | Pharmaceutical composition containing sodium thiosulfate |
US8404728B2 (en) | 2009-07-30 | 2013-03-26 | Mayo Foundation For Medical Education And Research | Small-molecule botulinum toxin inhibitors |
WO2011017389A1 (en) | 2009-08-05 | 2011-02-10 | Idenix Pharmaceuticals, Inc. | Macrocyclic serine protease inhibitors useful against viral infections, particularly hcv |
MX2012001974A (en) | 2009-08-19 | 2012-04-11 | Ambit Biosciences Corp | Biaryl compounds and methods of use thereof. |
US8470817B2 (en) * | 2009-10-26 | 2013-06-25 | Sunesis Pharmaceuticals, Inc. | Compounds and methods for treatment of cancer |
WO2011056764A1 (en) | 2009-11-05 | 2011-05-12 | Ambit Biosciences Corp. | Isotopically enriched or fluorinated imidazo[2,1-b][1,3]benzothiazoles |
WO2011057214A2 (en) | 2009-11-09 | 2011-05-12 | Neurogenetic Pharmaceuticals, Inc. | Gamma-secretase modulatory compounds, methods for identifying same, and uses therefor |
WO2011069002A1 (en) | 2009-12-02 | 2011-06-09 | Alquest Therapeutics, Inc. | Organoselenium compounds and uses thereof |
SG181797A1 (en) | 2009-12-18 | 2012-07-30 | Idenix Pharmaceuticals Inc | 5,5-fused arylene or heteroarylene hepatitis c virus inhibitors |
WO2011079313A1 (en) * | 2009-12-23 | 2011-06-30 | Map Pharmaceuticals, Inc. | Novel ergoline analogs |
WO2011094890A1 (en) | 2010-02-02 | 2011-08-11 | Argusina Inc. | Phenylalanine derivatives and their use as non-peptide glp-1 receptor modulators |
EP2542542B1 (en) | 2010-03-02 | 2015-04-22 | Axikin Pharmaceuticals, Inc. | Isotopically enriched arylsulfonamide ccr3 antagonists |
WO2011112689A2 (en) | 2010-03-11 | 2011-09-15 | Ambit Biosciences Corp. | Saltz of an indazolylpyrrolotriazine |
JP5818873B2 (en) | 2010-03-17 | 2015-11-18 | アクシキン ファーマシューティカルズ インコーポレーテッド | Arylsulfonamide CCR3 antagonist |
WO2011150198A1 (en) | 2010-05-27 | 2011-12-01 | Ambit Biosciences Corporation | Azolyl urea compounds and methods of use thereof |
WO2011150201A2 (en) | 2010-05-27 | 2011-12-01 | Ambit Biosciences Corporation | Azolyl amide compounds and methods of use thereof |
MX2012013879A (en) | 2010-06-01 | 2013-04-03 | Biotheryx Inc | Hydroxypyridone derivatives, pharmaceutical compositions thereof, and their therapeutic use for treating proliferative diseases. |
CN103153309A (en) | 2010-06-01 | 2013-06-12 | 拜欧赛里克斯公司 | Methods of treating hematologic malignancies using 6-cyclohexyl-1-hydroxy-4-methyl-2(1h)-pyridone |
AU2011265047B2 (en) | 2010-06-07 | 2014-10-23 | Novomedix, Llc | Furanyl compounds and the use thereof |
KR101545413B1 (en) | 2010-07-15 | 2015-08-18 | 아이노비아 인코포레이티드 | Drop generating device |
EA201390121A8 (en) | 2010-07-15 | 2014-02-28 | Коринтиан Офтэлмик, Инк. | METHOD AND SYSTEM FOR PERFORMING REMOTE TREATMENT AND CONTROL |
US10154923B2 (en) | 2010-07-15 | 2018-12-18 | Eyenovia, Inc. | Drop generating device |
AU2011278924B2 (en) | 2010-07-15 | 2015-06-18 | Eyenovia, Inc. | Ophthalmic drug delivery |
CA2805745C (en) | 2010-07-19 | 2019-01-15 | Summa Health System | Vitamin c and chromium-free vitamin k, and compositions thereof for treating an nfkb-mediated condition or disease |
US20140200270A1 (en) | 2013-01-11 | 2014-07-17 | Summa Health System | Vitamins c and k for treating polycystic diseases |
US9757528B2 (en) | 2010-08-23 | 2017-09-12 | Darren Rubin | Nebulizer having different negative pressure threshold settings |
CA3071911C (en) | 2010-08-23 | 2023-01-17 | Darren Rubin | Systems and methods of aerosol delivery with airflow regulation |
EP2448571B1 (en) | 2010-08-30 | 2013-06-12 | Pulmatrix, Inc. | Respirably dry powder comprising calcium lactate, sodium chloride and leucine |
EP2611438B1 (en) | 2010-08-30 | 2020-04-01 | Pulmatrix Operating Company, Inc. | Dry powder formulations and methods for treating pulmonary diseases |
WO2012030913A1 (en) | 2010-09-01 | 2012-03-08 | Ambit Biosciences Corporation | An optically active pyrazolylaminoquinazoline, and pharmaceutical compositions and methods of use thereof |
US20130225615A1 (en) | 2010-09-01 | 2013-08-29 | Ambit Biosciences Corporation | 2-cycloquinazoline derivatives and methods of use thereof |
EP2611809A1 (en) | 2010-09-01 | 2013-07-10 | Ambit Biosciences Corporation | Azolopyridine and azolopyrimidine compounds and methods of use thereof |
JP5872558B2 (en) | 2010-09-01 | 2016-03-01 | アムビト ビオスシエンセス コルポラチオン | Pyrazolylaminoquinazoline hydrobromide |
WO2012030912A1 (en) | 2010-09-01 | 2012-03-08 | Ambit Biosciences Corporation | 7-cyclylquinazoline derivatives and methods of use thereof |
US20130225614A1 (en) | 2010-09-01 | 2013-08-29 | Ambit Biosciences Corporation | 4-azolylaminoquinazoline derivatives and methods of use thereof |
EP2611502A1 (en) | 2010-09-01 | 2013-07-10 | Ambit Biosciences Corporation | Adenosine a3 receptor modulating compounds and methods of use thereof |
US20130317045A1 (en) | 2010-09-01 | 2013-11-28 | Ambit Biosciences Corporation | Thienopyridine and thienopyrimidine compounds and methods of use thereof |
CN103298805A (en) | 2010-09-01 | 2013-09-11 | 埃姆比特生物科学公司 | Quinazoline compounds and methods of use thereof |
WO2012030944A2 (en) | 2010-09-01 | 2012-03-08 | Ambit Biosciences Corporation | Quinoline and isoquinoline compounds and methods of use thereof |
CN103209728B (en) * | 2010-09-24 | 2015-10-14 | 多诺万·B.·耶茨 | The aerosol generator of compact, low flow resistance and operational approach thereof |
MX354828B (en) | 2010-09-29 | 2018-03-22 | Pulmatrix Operating Co Inc | Monovalent metal cation dry powders for inhalation. |
WO2012044641A1 (en) | 2010-09-29 | 2012-04-05 | Pathway Therapeutics Inc. | 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy |
DK3470057T3 (en) | 2010-09-29 | 2021-11-22 | Pulmatrix Operating Co Inc | CATIONIC DRY POWDER INCLUDING MAGNESIUM SALT |
AU2011313906B2 (en) | 2010-10-11 | 2015-08-13 | Axikin Pharmaceuticals, Inc. | Salts of arylsulfonamide CCR3 antagonists |
WO2012078649A1 (en) | 2010-12-06 | 2012-06-14 | Follica, Inc. | Methods for treating baldness and promoting hair growth |
WO2012080050A1 (en) | 2010-12-14 | 2012-06-21 | F. Hoffmann-La Roche Ag | Solid forms of a phenoxybenzenesulfonyl compound |
EP2668210B1 (en) | 2011-01-26 | 2020-06-17 | Celldex Therapeutics, Inc. | Anti-kit antibodies and uses thereof |
WO2012106299A1 (en) | 2011-01-31 | 2012-08-09 | Celgene Corporation | Pharmaceutical compositions of cytidine analogs and methods of use thereof |
WO2012109398A1 (en) | 2011-02-10 | 2012-08-16 | Idenix Pharmaceuticals, Inc. | Macrocyclic serine protease inhibitors, pharmaceutical compositions thereof, and their use for treating hcv infections |
US9399110B2 (en) | 2011-03-09 | 2016-07-26 | Chong Corporation | Medicant delivery system |
US9913950B2 (en) * | 2011-03-09 | 2018-03-13 | Chong Corporation | Medicant delivery system |
WO2012135160A1 (en) | 2011-03-28 | 2012-10-04 | Pathway Therapeutics Inc. | (alpha- substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5 -triazinyl benzimidazoles, pharmaceutical compositions containing them, and these compounds for use in treating proliferative diseases |
EP2691388A1 (en) | 2011-03-28 | 2014-02-05 | MEI Pharma, Inc. | (fused ring arylamino and heterocyclylamino) pyrimidynyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases |
EP2691389A1 (en) | 2011-03-28 | 2014-02-05 | MEI Pharma, Inc. | (alpha-substituted cycloalkylamino and heterocyclylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases |
US20120252721A1 (en) | 2011-03-31 | 2012-10-04 | Idenix Pharmaceuticals, Inc. | Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitor |
CN103827113A (en) | 2011-06-23 | 2014-05-28 | Map药物公司 | Novel fluoroergoline analogs |
WO2013037482A1 (en) | 2011-09-15 | 2013-03-21 | Phenex Pharmaceuticals Ag | Farnesoid x receptor agonists for cancer treatment and prevention |
WO2013056070A2 (en) | 2011-10-14 | 2013-04-18 | Ambit Biosciences Corporation | Heterocyclic compounds and methods of use thereof |
WO2013090459A1 (en) | 2011-12-12 | 2013-06-20 | Corinthian Ophthalmic, Inc. | Ejector mechanism, ejector device, and methods of use |
CA2859173A1 (en) | 2011-12-19 | 2013-06-27 | Map Pharmaceuticals, Inc. | Novel iso-ergoline derivatives |
WO2013095708A1 (en) | 2011-12-21 | 2013-06-27 | Map Pharmaceuticals, Inc. | Novel neuromodulatory compounds |
PL2797448T5 (en) * | 2011-12-30 | 2019-12-31 | Philip Morris Products S.A. | Aerosol generating device with air flow detection |
WO2013130600A1 (en) | 2012-02-29 | 2013-09-06 | Ambit Biosciences Corporation | Solid forms comprising optically active pyrazolylaminoquinazoline, compositions thereof, and uses therewith |
CN104302640A (en) | 2012-03-16 | 2015-01-21 | 埃克希金医药品有限公司 | 3,5-diaminopyrazole kinase inhibitors |
SI2844637T1 (en) | 2012-05-02 | 2018-07-31 | Boehringer Ingelheim International Gmbh | Substituted 3-haloallylamine inhibitors of ssao and uses thereof |
EP2861562B1 (en) | 2012-06-14 | 2018-05-09 | Mayo Foundation For Medical Education And Research | Pyrazole derivatives as inhibitors of stat3 |
US9012640B2 (en) | 2012-06-22 | 2015-04-21 | Map Pharmaceuticals, Inc. | Cabergoline derivatives |
KR101313993B1 (en) * | 2012-07-24 | 2013-10-01 | 한국화학연구원 | Nebulizer |
US9334332B2 (en) | 2012-07-25 | 2016-05-10 | Kolltan Pharmaceuticals, Inc. | Anti-kit antibodies |
US9074186B2 (en) | 2012-08-15 | 2015-07-07 | Boston Medical Center Corporation | Production of red blood cells and platelets from stem cells |
AU2013312420A1 (en) | 2012-09-07 | 2015-02-26 | Axikin Pharmaceuticals, Inc. | Isotopically enriched arylsulfonamide CCR3 antagonists |
WO2014055647A1 (en) | 2012-10-03 | 2014-04-10 | Mei Pharma, Inc. | (sulfinyl and sulfonyl benzimidazolyl) pyrimidines and triazines, pharmaceutical compositions thereof, and their use for treating proliferative diseases |
CA2890177A1 (en) | 2012-11-08 | 2014-05-15 | Summa Health System | Vitamin c, vitamin k, a polyphenol, and combinations thereof for wound healing |
US10034988B2 (en) | 2012-11-28 | 2018-07-31 | Fontem Holdings I B.V. | Methods and devices for compound delivery |
ES2689921T3 (en) | 2012-11-30 | 2018-11-16 | Novomedix, Llc | Substituted biarylsulfonamides and their uses |
US9169214B2 (en) | 2012-12-21 | 2015-10-27 | The Board Of Trustees Of The Leland Stanford Junior University | Compounds and compositions that bind and stabilize transthyretin and their use for inhibiting transthyretin amyloidosis and protein-protein interactions |
SG11201504931SA (en) | 2012-12-21 | 2015-07-30 | Map Pharmaceuticals Inc | Novel methysergide derivatives |
CN105473133A (en) | 2013-04-30 | 2016-04-06 | 欧缇托匹克公司 | Dry powder formulations and methods of use |
SG11201509982UA (en) | 2013-06-06 | 2016-04-28 | Igenica Biotherapeutics Inc | |
CN105683182A (en) | 2013-08-30 | 2016-06-15 | 埃姆比特生物科学公司 | Biaryl acetamide compounds and methods of use thereof |
NZ631142A (en) | 2013-09-18 | 2016-03-31 | Axikin Pharmaceuticals Inc | Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitors |
US20160229866A1 (en) | 2013-09-20 | 2016-08-11 | Idenix Pharmaceuticals Inc. | Hepatitis c virus inhibitors |
WO2015042412A1 (en) * | 2013-09-20 | 2015-03-26 | E-Nicotine Technology. Inc. | Devices and methods for modifying delivery devices |
US9782211B2 (en) | 2013-10-01 | 2017-10-10 | Uptake Medical Technology Inc. | Preferential volume reduction of diseased segments of a heterogeneous lobe |
JP7051293B2 (en) | 2013-10-24 | 2022-04-11 | アムジエン・インコーポレーテツド | Drug delivery system with temperature sensing control |
CA2977083A1 (en) | 2014-02-20 | 2015-08-27 | Kambiz Yadidi | Dry powder formulations for inhalation |
JP6870988B2 (en) | 2014-02-24 | 2021-05-19 | セルジーン コーポレイション | How to use cereblon activators for neuronal amplification and treatment of central nervous system disorders |
GB201403775D0 (en) | 2014-03-04 | 2014-04-16 | Kymab Ltd | Antibodies, uses & methods |
EP3114122A1 (en) | 2014-03-05 | 2017-01-11 | Idenix Pharmaceuticals LLC | Solid forms of a flaviviridae virus inhibitor compound and salts thereof |
US10202398B2 (en) | 2014-03-20 | 2019-02-12 | Capella Therapeutics, Inc. | Benzimidazole derivatives as ERBB tyrosine kinase inhibitors for the treatment of cancer |
CA2943220C (en) | 2014-03-20 | 2024-01-16 | Capella Therapeutics, Inc. | Benzimidazole derivatives as erbb tyrosine kinase inhibitors for the treatment of cancer |
AU2015259471A1 (en) | 2014-05-12 | 2016-11-24 | Conatus Pharmaceuticals, Inc. | Treatment of the complications of chronic liver disease with caspase inhibitors |
MA47849A (en) | 2014-05-28 | 2020-01-29 | Agenus Inc | ANTI-GITR ANTIBODIES AND THEIR METHODS OF USE |
US9527815B2 (en) | 2014-06-18 | 2016-12-27 | Biotheryx, Inc. | Hydroxypyridone derivatives, pharmaceutical compositions thereof, and their therapeutic use for treating inflammatory, neurodegenerative, or immune-mediated diseases |
US9499514B2 (en) | 2014-07-11 | 2016-11-22 | Celgene Corporation | Antiproliferative compounds and methods of use thereof |
WO2016025129A1 (en) | 2014-08-14 | 2016-02-18 | Alhamadsheh Mamoun M | Conjugation of pharmaceutically active agents with transthyretin ligands through adjustable linkers to increase serum half-life |
US11350669B2 (en) * | 2014-08-22 | 2022-06-07 | Njoy, Llc | Heating control for vaporizing device |
SG10201902137PA (en) | 2014-09-12 | 2019-04-29 | Tobira Therapeutics Inc | Cenicriviroc combination therapy for the treatment of fibrosis |
US20170354639A1 (en) | 2014-10-24 | 2017-12-14 | Biogen Ma Inc. | Diterpenoid derivatives and methods of use thereof |
US10485604B2 (en) | 2014-12-02 | 2019-11-26 | Uptake Medical Technology Inc. | Vapor treatment of lung nodules and tumors |
EP3229838B1 (en) | 2014-12-11 | 2020-09-09 | Pierre Fabre Medicament | Anti-c10orf54 antibodies and uses thereof |
EP3789039A1 (en) | 2014-12-22 | 2021-03-10 | The Rockefeller University | Anti-mertk agonistic antibodies and uses thereof |
MY191736A (en) | 2014-12-23 | 2022-07-13 | Axikin Pharmaceuticals Inc | 3,5-diaminopyrazole kinase inhibitors |
US9657020B2 (en) | 2015-01-20 | 2017-05-23 | Xoc Pharmaceuticals, Inc. | Ergoline compounds and uses thereof |
BR112017015510A2 (en) | 2015-01-20 | 2018-01-30 | Xoc Pharmaceuticals Inc | compound of formula (i), method of treatment and / or prevention, d2 receptor agonizing method in one individual, d3 receptor antagonizing method in one individual, 5-ht1d receptor agonizing method in one individual, 5-ht1a receptor agonization in one individual, selective 5-ht1d receptor agonizing method instead of 5-ht1b receptor in one individual, 5-ht2c re-receptor selective agonizing method instead of 5-ht2a or 5 receptor -ht2b in one individual, method of 5-ht2c receptor agonization in one individual, method of providing functional antagonist activity at 5-ht2b receptor or 5-ht7 receptor, and, method of providing functional antagonist activity at adrenergic receptors in one individual |
CN107428749B (en) | 2015-01-28 | 2020-07-24 | 上海复旦张江生物医药股份有限公司 | Substituted imidazo [1,2- α ] pyridin-2-ylamine compounds, pharmaceutical compositions and methods of use thereof |
US10531906B2 (en) | 2015-02-02 | 2020-01-14 | Uptake Medical Technology Inc. | Medical vapor generator |
WO2016139482A1 (en) | 2015-03-03 | 2016-09-09 | Kymab Limited | Antibodies, uses & methods |
SG10201913500TA (en) | 2015-05-29 | 2020-03-30 | Agenus Inc | Anti-ctla-4 antibodies and methods of use thereof |
KR20180015260A (en) | 2015-06-23 | 2018-02-12 | 뉴로크린 바이오사이언시즈 인코퍼레이티드 | VMAT2 inhibitors for the treatment of neurological diseases or disorders |
EA201890630A1 (en) | 2015-09-01 | 2018-10-31 | Эйдженус Инк. | ANTIBODIES AGAINST PD-1 AND METHODS OF THEIR APPLICATION |
CN115322188A (en) | 2015-10-30 | 2022-11-11 | 纽罗克里生物科学有限公司 | VALBENAZINE salts and polymorphs thereof |
WO2017079566A1 (en) | 2015-11-05 | 2017-05-11 | Conatus Pharmaceuticals, Inc. | Caspase inhibitors for use in the treatment of liver cancer |
US10112924B2 (en) | 2015-12-02 | 2018-10-30 | Astraea Therapeutics, Inc. | Piperdinyl nociceptin receptor compounds |
HUE059065T2 (en) | 2015-12-23 | 2022-10-28 | Neurocrine Biosciences Inc | Synthetic method for preparation of (s)-(2r,3r,11br)-3-isobutyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1h-pyrido[2,1,-a]lsoquinolin-2-yl 2-amino-3-methylbutanoate di(4-methylbenzenesulfonate) |
CN108697663A (en) | 2015-12-31 | 2018-10-23 | 科内图斯医药公司 | The method that caspase inhibitors are used in liver disease |
AR107320A1 (en) | 2016-01-08 | 2018-04-18 | Celgene Corp | SOLID FORMS OF 2- (4-CHLOROPHENYL) -N - ((2- (2,6-DIOXOPIPERIDIN-3-IL) -1-OXOINDOLIN-5-IL) METHYL) -2,2-DIFLUOROACETAMIDE AND ITS PHARMACEUTICAL COMPOSITIONS AND APPLICATIONS |
WO2017120422A1 (en) | 2016-01-08 | 2017-07-13 | Celgene Corporation | Antiproliferative compounds, and their pharmaceutical compositions and uses |
US10960013B2 (en) | 2016-03-04 | 2021-03-30 | East Carolina University | J-series prostaglandin-ethanolamides as novel therapeutics for skin and/or oral disorders |
US10064855B2 (en) | 2016-03-08 | 2018-09-04 | Los Gatos Pharmaceuticals, Inc. | Composite nanoparticles and uses thereof |
JP2019513151A (en) | 2016-03-08 | 2019-05-23 | ロス ガトス ファーマスーティカルズ, インク.Los Gatos Pharmaceuticals, Inc. | Camptothecin derivatives and uses thereof |
EP3442940A1 (en) | 2016-04-11 | 2019-02-20 | Clexio Biosciences Ltd. | Deuterated ketamine derivatives |
WO2017180794A1 (en) | 2016-04-13 | 2017-10-19 | Skyline Antiinfectives, Inc. | Deuterated o-sulfated beta-lactam hydroxamic acids and deuterated n-sulfated beta-lactams |
ES2939373T3 (en) | 2016-05-13 | 2023-04-21 | Pasteur Institut | Inhibition of beta-2 nicotinic acetylcholine receptors to treat Alzheimer's disease pathology |
TWI753910B (en) | 2016-05-16 | 2022-02-01 | 美商拜歐斯瑞克斯公司 | Pyridinethiones, pharmaceutical compositions thereof, and their therapeutic use for treating a proliferative, inflammatory, neurodegenerative, or immune-mediated disease |
MX2018014387A (en) | 2016-05-27 | 2019-03-14 | Agenus Inc | Anti-tim-3 antibodies and methods of use thereof. |
CA3028604C (en) | 2016-07-08 | 2023-12-05 | Trudell Medical International | Smart oscillating positive expiratory pressure device |
KR20190039937A (en) | 2016-07-08 | 2019-04-16 | 스태튼 바이오테크놀로지 비.브이. | Anti-ApoC3 antibodies and methods of use thereof |
WO2018035281A1 (en) | 2016-08-17 | 2018-02-22 | North Carolina State University | Northern-southern route to synthesis of bacteriochlorins |
JP2019529419A (en) | 2016-09-19 | 2019-10-17 | エムイーアイ ファーマ,インク. | Combination therapy |
GB201616430D0 (en) | 2016-09-28 | 2016-11-09 | Nicoventures Holdings Limited | Liquid storage tank for a vapour provision system |
TW202246349A (en) | 2016-10-11 | 2022-12-01 | 美商艾吉納斯公司 | Anti-lag-3 antibodies and methods of use thereof |
US11779604B2 (en) | 2016-11-03 | 2023-10-10 | Kymab Limited | Antibodies, combinations comprising antibodies, biomarkers, uses and methods |
WO2018083538A1 (en) | 2016-11-07 | 2018-05-11 | Neuracle Scienc3 Co., Ltd. | Anti-family with sequence similarity 19, member a5 antibodies and method of use thereof |
US10106521B2 (en) | 2016-11-09 | 2018-10-23 | Phloronol, Inc. | Eckol derivatives, methods of synthesis and uses thereof |
CN116987014A (en) | 2016-11-09 | 2023-11-03 | 诺沃梅迪科斯有限公司 | Nitrite salts of 1, 1-metformin, pharmaceutical compositions and methods of use |
US10836774B2 (en) | 2016-11-30 | 2020-11-17 | North Carolina State University | Methods for making bacteriochlorin macrocycles comprising an annulated isocyclic ring and related compounds |
US10799503B2 (en) | 2016-12-01 | 2020-10-13 | Ignyta, Inc. | Methods for the treatment of cancer |
TW202345829A (en) | 2016-12-02 | 2023-12-01 | 美商紐羅克里生物科學有限公司 | Use of valbenazine for treating schizophrenia or schizoaffective disorder |
MX2019006340A (en) | 2016-12-07 | 2019-11-07 | Agenus Inc | Anti-ctla-4 antibodies and methods of use thereof. |
CA3046082A1 (en) | 2016-12-07 | 2018-06-14 | Agenus Inc. | Antibodies and methods of use thereof |
CA3036631A1 (en) | 2016-12-09 | 2018-06-14 | Trudell Medical International | Smart nebulizer |
GB201701102D0 (en) | 2017-01-23 | 2017-03-08 | Nicoventures Holdings Ltd | Electronic vapour provision system |
JP7199361B2 (en) | 2017-01-27 | 2023-01-05 | ニューロクライン バイオサイエンシーズ,インコーポレイテッド | Methods for administering certain VMAT2 inhibitors |
BR112019017260A2 (en) | 2017-02-17 | 2020-04-14 | Camris Int Inc | universal antivenom |
MX2019009764A (en) | 2017-02-17 | 2019-11-11 | Eidos Therapeutics Inc | Processes for preparing ag-10, its intermediates, and salts thereof. |
WO2018164996A1 (en) | 2017-03-06 | 2018-09-13 | Neurocrine Biosciences, Inc. | Dosing regimen for valbenazine |
US20200330590A1 (en) | 2017-03-27 | 2020-10-22 | Celgene Corporation | Methods and compositions for reduction of immunogenicity |
BR112019017241A2 (en) | 2017-04-13 | 2020-04-14 | Agenus Inc | anti-cd137 antibodies and methods of using them |
CN110506056A (en) | 2017-04-21 | 2019-11-26 | 斯塔滕生物技术有限公司 | Anti- APOC3 antibody and its application method |
US20200179352A1 (en) | 2017-04-26 | 2020-06-11 | Neurocrine Biosciences, Inc. | Use of valbenazine for treating levodopa-induced dyskinesia |
EP3618863B1 (en) | 2017-05-01 | 2023-07-26 | Agenus Inc. | Anti-tigit antibodies and methods of use thereof |
US11129673B2 (en) | 2017-05-05 | 2021-09-28 | Uptake Medical Technology Inc. | Extra-airway vapor ablation for treating airway constriction in patients with asthma and COPD |
JOP20190219A1 (en) | 2017-05-09 | 2019-09-22 | Cardix Therapeutics LLC | Pharmaceutical compositions and methods of treating cardiovascular diseases |
US10085999B1 (en) | 2017-05-10 | 2018-10-02 | Arixa Pharmaceuticals, Inc. | Beta-lactamase inhibitors and uses thereof |
WO2018223065A1 (en) | 2017-06-01 | 2018-12-06 | Xoc Pharmaceuticals, Inc. | Ergoline derivatives for use in medicine |
JP7227163B2 (en) | 2017-06-10 | 2023-02-21 | アイノビア,インコーポレイティド | Methods and apparatus for handling and delivering fluids to the eye |
EP3645044A4 (en) | 2017-06-27 | 2021-04-28 | Neuracle Science Co., Ltd | Use of anti-family with sequence similarity 19, member a5 antibodies for the treatment of glaucoma |
WO2019003164A1 (en) | 2017-06-27 | 2019-01-03 | Neuracle Science Co., Ltd. | Use of anti-fam19a5 antibodies for treating cancers |
EP3645039A4 (en) | 2017-06-27 | 2021-05-05 | Neuracle Science Co., Ltd | Use of anti-fam19a5 antibodies for treating fibrosis |
JP7076059B2 (en) | 2017-06-27 | 2022-05-27 | ニューラクル サイエンス カンパニー リミテッド | Anti-FAM19A5 antibody and its uses |
GB201713681D0 (en) | 2017-08-25 | 2017-10-11 | Nicoventures Holdings Ltd | Vapour provision systems |
ES2953032T3 (en) | 2017-09-01 | 2023-11-07 | Univ East Carolina | Ex vivo methods for the activation of immune cells |
US11344364B2 (en) | 2017-09-07 | 2022-05-31 | Uptake Medical Technology Inc. | Screening method for a target nerve to ablate for the treatment of inflammatory lung disease |
US11350988B2 (en) | 2017-09-11 | 2022-06-07 | Uptake Medical Technology Inc. | Bronchoscopic multimodality lung tumor treatment |
USD845467S1 (en) | 2017-09-17 | 2019-04-09 | Uptake Medical Technology Inc. | Hand-piece for medical ablation catheter |
CN111372567B (en) | 2017-09-21 | 2024-03-15 | 纽罗克里生物科学有限公司 | High dose valphenazine formulations and compositions, methods and kits relating thereto |
SG11202003194YA (en) | 2017-10-10 | 2020-05-28 | Neurocrine Biosciences Inc | Methods for the administration of certain vmat2 inhibitors |
US10993941B2 (en) | 2017-10-10 | 2021-05-04 | Neurocrine Biosciences, Inc. | Methods for the administration of certain VMAT2 inhibitors |
CA3080103A1 (en) | 2017-10-31 | 2019-05-09 | Staten Biotechnology B.V. | Anti-apoc3 antibodies and methods of use thereof |
US11419658B2 (en) | 2017-11-06 | 2022-08-23 | Uptake Medical Technology Inc. | Method for treating emphysema with condensable thermal vapor |
US11490946B2 (en) | 2017-12-13 | 2022-11-08 | Uptake Medical Technology Inc. | Vapor ablation handpiece |
EA037169B1 (en) * | 2017-12-26 | 2021-02-15 | Общество с ограниченной ответственностью "Научно-производственный Инновационный внедренческий центр" | Method of generating a medication in aerosol form |
US11666801B2 (en) | 2018-01-04 | 2023-06-06 | Trudell Medical International | Smart oscillating positive expiratory pressure device |
TW201929847A (en) | 2018-01-10 | 2019-08-01 | 美商克拉治療有限責任公司 | Pharmaceutical compositions comprising dicarboxylic acids and their therapeutic applications |
US11701334B2 (en) | 2018-01-10 | 2023-07-18 | Cura Therapeutics, Llc | Pharmaceutical compositions comprising phenylsulfonamides, and their therapeutic applications |
AU2019209228B2 (en) * | 2018-01-19 | 2023-09-07 | Ventus Medical Limited | Methods, inhalation device, and computer program |
EP3768841A4 (en) | 2018-03-23 | 2021-12-08 | Eidos Therapeutics, Inc. | Methods of treating ttr amyloidosis using ag10 |
US11634484B2 (en) | 2018-04-24 | 2023-04-25 | Neuracle Science Co., Ltd. | Use of anti-family with sequence similarity 19, member A5 antibodies for the treatment of neuropathic pain |
CN112638387A (en) | 2018-06-14 | 2021-04-09 | 纽罗克里生物科学有限公司 | VMAT2 inhibitor compounds, compositions, and methods related thereto |
WO2020006341A1 (en) | 2018-06-29 | 2020-01-02 | Conatus Pharmaceuticals, Inc. | (s)-3-(2-(4-(benzyl)-3-oxopiperazin-1-yl)acetamido)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid derivatives and related compounds as caspase inhibitors for treating cardiovascular diseases |
BR112021000934A2 (en) | 2018-07-20 | 2021-04-27 | Pierre Fabre Medicament | receiver for sight |
EP3836926A4 (en) | 2018-08-15 | 2022-05-04 | Neurocrine Biosciences, Inc. | Methods for the administration of certain vmat2 inhibitors |
BR112020026493A2 (en) | 2018-08-17 | 2021-03-23 | Eidos Therapeutics, Inc. | AG10 FORMULATIONS |
CN112969503A (en) | 2018-10-03 | 2021-06-15 | 斯塔滕生物技术有限公司 | Antibodies specific for human and cynomolgus macaques APOC3 and methods of use thereof |
CA3119341A1 (en) | 2018-11-16 | 2020-05-22 | Neoimmunetech, Inc. | Method of treating a tumor with a combination of il-7 protein and an immune checkpoint inhibitor |
KR20200071198A (en) | 2018-12-10 | 2020-06-19 | 네오이뮨텍, 인코퍼레이티드 | Development of new adoptive T cell immunotherapy by modification of Nrf2 expression |
EP3898609A1 (en) | 2018-12-19 | 2021-10-27 | Shy Therapeutics LLC | Compounds that interact with the ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease |
US11447468B2 (en) | 2019-02-06 | 2022-09-20 | Dice Alpha, Inc. | IL-17 ligands and uses thereof |
US11653927B2 (en) | 2019-02-18 | 2023-05-23 | Uptake Medical Technology Inc. | Vapor ablation treatment of obstructive lung disease |
MA55080A (en) | 2019-02-26 | 2022-01-05 | Inspirna Inc | HIGH AFFINITY ANTI-MERTK ANTIBODIES AND ASSOCIATED USES |
EP3930807B1 (en) * | 2019-02-27 | 2023-11-08 | NuvoAir AB | A method and a device for estimating an amount of a powder shaped material passing a bend in a flow channel |
WO2020181165A1 (en) | 2019-03-07 | 2020-09-10 | Conatus Pharmaceuticals Inc. | Caspase inhibitors and methods of use thereof |
CN114222803A (en) | 2019-05-20 | 2022-03-22 | 尼尔瓦纳科学股份有限公司 | Narrow emission dyes, compositions comprising the same, and methods of making and using the same |
CA3146157A1 (en) | 2019-07-11 | 2021-01-14 | Cura Therapeutics, Llc | Sulfone compounds and pharmaceutical compositions thereof, and their therapeutic applications for the treatment of neurodegenerative diseases |
EP3996813A1 (en) | 2019-07-11 | 2022-05-18 | Cura Therapeutics, LLC | Phenyl compounds and pharmaceutical compositions thereof, and their therapeutic applications |
US10940141B1 (en) | 2019-08-23 | 2021-03-09 | Neurocrine Biosciences, Inc. | Methods for the administration of certain VMAT2 inhibitors |
CA3152072A1 (en) | 2019-08-27 | 2021-03-04 | Trudell Medical International | Smart oscillating positive expiratory pressure device |
US11680098B2 (en) | 2019-08-30 | 2023-06-20 | Agenus Inc. | Antibodies that specifically bind human CD96 |
WO2021055376A1 (en) | 2019-09-16 | 2021-03-25 | Dice Alpha, Inc. | Il-17a modulators and uses thereof |
CN114945409A (en) | 2020-01-13 | 2022-08-26 | 新免疫技术有限公司 | Methods of treating tumors with combinations of IL-7 proteins and bispecific antibodies |
WO2021151001A1 (en) | 2020-01-22 | 2021-07-29 | Outpace Bio, Inc. | Chimeric polypeptides |
AU2021217373A1 (en) | 2020-02-05 | 2022-08-04 | Neoimmunetech, Inc. | Method of treating a solid tumor with a combination of an IL-7 protein and CAR-bearing immune cells |
US11278688B2 (en) * | 2020-03-12 | 2022-03-22 | Max Azevedo | Inhaling device for heavy metal salts and a method of use thereof for medical treatment |
EP4138884A1 (en) | 2020-04-20 | 2023-03-01 | Sorrento Therapeutics, Inc. | Pulmonary administration of ace2 polypeptides |
WO2021242970A1 (en) | 2020-05-29 | 2021-12-02 | Boulder Bioscience Llc | Methods for improved endovascular thrombectomy using 3,3'-diindolylmethane |
EP4168414A1 (en) | 2020-06-18 | 2023-04-26 | Shy Therapeutics LLC | Substituted thienopyrimidines that interact with the ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease |
WO2022061348A1 (en) | 2020-09-16 | 2022-03-24 | Biotheryx, Inc. | Sos1 protein degraders, pharmaceutical compositions thereof, and their therapeutic applications |
WO2022087335A1 (en) | 2020-10-23 | 2022-04-28 | Biotheryx, Inc. | Kras protein degraders, pharmaceutical compositions thereof, and their therapeutic applications |
KR20230104176A (en) | 2020-11-02 | 2023-07-07 | 네오이뮨텍, 인코퍼레이티드 | Use of interleukin-7 for treatment of coronavirus |
KR20230104175A (en) | 2020-11-05 | 2023-07-07 | 네오이뮨텍, 인코퍼레이티드 | Methods of Treating Tumors Using Combinations of IL-7 Protein and Nucleotide Vaccines |
JP2024500377A (en) | 2020-12-14 | 2024-01-09 | バイオセリックス, インコーポレイテッド | PDE4 degraders, pharmaceutical compositions, and therapeutic applications |
EP4284377A1 (en) | 2021-01-27 | 2023-12-06 | Shy Therapeutics LLC | Methods for the treatment of fibrotic disease |
WO2022165000A1 (en) | 2021-01-27 | 2022-08-04 | Shy Therapeutics, Llc | Methods for the treatment of fibrotic disease |
AU2022232625A1 (en) | 2021-03-10 | 2023-09-28 | Dice Molecules Sv, Inc. | Alpha v beta 6 and alpha v beta 1 integrin inhibitors and uses thereof |
EP4326721A1 (en) | 2021-04-22 | 2024-02-28 | Protego Biopharma, Inc. | Spirocyclic imidazolidinones and imidazolidinediones for treatment of light chain amyloidosis |
EP4347568A1 (en) | 2021-05-27 | 2024-04-10 | Protego Biopharma, Inc. | Heteroaryl diamide ire1/xbp1s activators |
WO2022251644A1 (en) | 2021-05-28 | 2022-12-01 | Lyell Immunopharma, Inc. | Nr4a3-deficient immune cells and uses thereof |
EP4347826A1 (en) | 2021-06-02 | 2024-04-10 | Lyell Immunopharma, Inc. | Nr4a3-deficient immune cells and uses thereof |
IL309349A (en) | 2021-06-14 | 2024-02-01 | argenx BV | Anti-il-9 antibodies and methods of use thereof |
EP4355741A1 (en) | 2021-06-16 | 2024-04-24 | Biotheryx, Inc. | Sos1 protein degraders, pharmaceutical compositions thereof, and their therapeutic applications |
WO2022266249A1 (en) | 2021-06-16 | 2022-12-22 | Biotheryx, Inc. | Kras protein degraders, pharmaceutical compositions thereof, and their therapeutic applications |
WO2023055045A1 (en) | 2021-09-29 | 2023-04-06 | 주식회사 엔바이오스 | Coiled-coil fusion protein |
WO2023081923A1 (en) | 2021-11-08 | 2023-05-11 | Frequency Therapeutics, Inc. | Platelet-derived growth factor receptor (pdgfr) alpha inhibitors and uses thereof |
WO2023130081A1 (en) | 2021-12-30 | 2023-07-06 | Neoimmunetech, Inc. | Method of treating a tumor with a combination of il-7 protein and vegf antagonist |
WO2023129577A1 (en) | 2022-01-03 | 2023-07-06 | Lilac Therapeutics, Inc. | Cyclic thiol prodrugs |
US20230348909A1 (en) | 2022-03-30 | 2023-11-02 | Biomarin Pharmaceutical Inc. | Dystrophin exon skipping oligonucleotides |
GB2619907A (en) | 2022-04-01 | 2023-12-27 | Kanna Health Ltd | Novel crystalline salt forms of mesembrine |
WO2023201282A1 (en) | 2022-04-14 | 2023-10-19 | Bristol-Myers Squibb Company | Novel gspt1 compounds and methods of use of the novel compounds |
US20230416741A1 (en) | 2022-05-05 | 2023-12-28 | Biomarin Pharmaceutical Inc. | Method of treating duchenne muscular dystrophy |
WO2023220640A1 (en) | 2022-05-10 | 2023-11-16 | Biotheryx, Inc. | Cdk protein degraders, pharmaceutical compositions, and therapeutic applications |
WO2023225665A1 (en) | 2022-05-19 | 2023-11-23 | Lyell Immunopharma, Inc. | Polynucleotides targeting nr4a3 and uses thereof |
WO2024054832A1 (en) | 2022-09-09 | 2024-03-14 | Innovo Therapeutics, Inc. | CK1α AND DUAL CK1α / GSPT1 DEGRADING COMPOUNDS |
WO2024073473A1 (en) | 2022-09-30 | 2024-04-04 | Boulder Bioscience Llc | Compositions comprising 3,3'-diindolylmethane for treating non-hemorrhagic closed head injury |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4587966A (en) * | 1982-09-17 | 1986-05-13 | Dragerwerk Aktiengesellschaft | Device for evaluating the mixing of liquid anesthetic and a respiratory gas for patients |
US4653494A (en) * | 1985-12-20 | 1987-03-31 | Ruderian Max J | Nasal inhalation system |
US5038769A (en) * | 1983-06-29 | 1991-08-13 | Krauser Robert S | Method and apparatus for treating ailments |
US5404871A (en) | 1991-03-05 | 1995-04-11 | Aradigm | Delivery of aerosol medications for inspiration |
US5497763A (en) | 1993-05-21 | 1996-03-12 | Aradigm Corporation | Disposable package for intrapulmonary delivery of aerosolized formulations |
US5709202A (en) | 1993-05-21 | 1998-01-20 | Aradigm Corporation | Intrapulmonary delivery of aerosolized formulations |
Family Cites Families (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2320573A1 (en) * | 1972-05-02 | 1973-11-22 | Intergadgets Ag | DEVICE FOR EVAPORATING SUBSTANCES |
US3949743A (en) * | 1973-03-19 | 1976-04-13 | Schick Incorporated | Medicated vapor production method and apparatus |
US3933276A (en) * | 1974-12-09 | 1976-01-20 | The Gillette Company | Heating and dispensing apparatus |
US4106503A (en) * | 1977-03-11 | 1978-08-15 | Richard R. Rosenthal | Metering system for stimulating bronchial spasm |
US4419302A (en) * | 1979-09-29 | 1983-12-06 | Matsushita Electric Industrial Company, Limited | Steam generator |
US4365141A (en) * | 1981-01-05 | 1982-12-21 | Jerdon Industries, Inc. | Hair dryer |
US4682010A (en) * | 1983-03-07 | 1987-07-21 | Safeway Products, Inc. | In-line electric heater for an aerosol delivery system |
US4523589A (en) * | 1983-06-29 | 1985-06-18 | Krauser Robert S | Method and apparatus for treating ailments |
US4735217A (en) * | 1986-08-21 | 1988-04-05 | The Procter & Gamble Company | Dosing device to provide vaporized medicament to the lungs as a fine aerosol |
US4733059A (en) * | 1987-06-15 | 1988-03-22 | Thermon Manufacturing Company | Elongated parallel, constant wattage heating cable |
US4911157A (en) * | 1988-01-07 | 1990-03-27 | Pegasus Research Corporation | Self-regulating, heated nebulizer system |
US4947875A (en) * | 1988-09-08 | 1990-08-14 | R. J. Reynolds Tobacco Company | Flavor delivery articles utilizing electrical energy |
US4922901A (en) * | 1988-09-08 | 1990-05-08 | R. J. Reynolds Tobacco Company | Drug delivery articles utilizing electrical energy |
US5665262A (en) * | 1991-03-11 | 1997-09-09 | Philip Morris Incorporated | Tubular heater for use in an electrical smoking article |
US5249586A (en) * | 1991-03-11 | 1993-10-05 | Philip Morris Incorporated | Electrical smoking |
US5246018A (en) * | 1991-07-19 | 1993-09-21 | Philip Morris Incorporated | Manufacturing of composite heat sources containing carbon and metal species |
US5383113A (en) * | 1991-07-25 | 1995-01-17 | Checkfree Corporation | System and method for electronically providing customer services including payment of bills, financial analysis and loans |
US5284133A (en) * | 1992-07-23 | 1994-02-08 | Armstrong Pharmaceuticals, Inc. | Inhalation device with a dose-timer, an actuator mechanism, and patient compliance monitoring means |
US5283829A (en) * | 1992-10-01 | 1994-02-01 | Bell Communications Research, Inc. | System and method for paying bills electronically |
US5504677A (en) * | 1992-10-15 | 1996-04-02 | Pollin; Robert E. | Automated payment system |
US5672581A (en) * | 1993-01-29 | 1997-09-30 | Aradigm Corporation | Method of administration of insulin |
US5388574A (en) * | 1993-07-29 | 1995-02-14 | Ingebrethsen; Bradley J. | Aerosol delivery article |
DE4328243C1 (en) * | 1993-08-19 | 1995-03-09 | Sven Mielordt | Smoke or inhalation device |
US5465206B1 (en) * | 1993-11-01 | 1998-04-21 | Visa Int Service Ass | Electronic bill pay system |
GB2284356B (en) * | 1993-11-22 | 1997-10-29 | Fisher & Paykel | Respiratory humidifier conduit |
US5522385A (en) * | 1994-09-27 | 1996-06-04 | Aradigm Corporation | Dynamic particle size control for aerosolized drug delivery |
US5743251A (en) * | 1996-05-15 | 1998-04-28 | Philip Morris Incorporated | Aerosol and a method and apparatus for generating an aerosol |
AUPO214096A0 (en) * | 1996-09-04 | 1996-09-26 | Telefonaktiebolaget Lm Ericsson (Publ) | A telecommunications system and method for automatic call recognition and distribution |
US6131570A (en) * | 1998-06-30 | 2000-10-17 | Aradigm Corporation | Temperature controlling device for aerosol drug delivery |
US6195419B1 (en) * | 1997-12-24 | 2001-02-27 | At&T Corp. | Subaccount direct billing method and apparatus |
US5906282A (en) * | 1998-03-18 | 1999-05-25 | Northwestern Industries Incorporated | Indexable glass shipping apparatus |
FR2816422B1 (en) * | 2000-11-06 | 2003-04-04 | Noemi | METHOD FOR THE PAYMENT OF TRANSACTIONS CARRIED OUT FOR EXAMPLE ON THE INTERNET |
-
1998
- 1998-06-30 US US09/107,306 patent/US6131570A/en not_active Expired - Fee Related
-
1999
- 1999-06-29 JP JP2000556828A patent/JP2002519120A/en active Pending
- 1999-06-29 WO PCT/US1999/014762 patent/WO2000000244A1/en active IP Right Grant
- 1999-06-29 EP EP99932072A patent/EP1091778A4/en not_active Withdrawn
- 1999-06-29 CA CA002335553A patent/CA2335553A1/en not_active Abandoned
- 1999-06-29 AU AU48462/99A patent/AU759358B2/en not_active Ceased
-
2000
- 2000-10-16 US US09/690,242 patent/US6263872B1/en not_active Expired - Fee Related
-
2001
- 2001-04-20 US US09/839,248 patent/US6629526B2/en not_active Expired - Fee Related
-
2003
- 2003-07-11 US US10/618,064 patent/US6845216B2/en not_active Expired - Fee Related
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4587966A (en) * | 1982-09-17 | 1986-05-13 | Dragerwerk Aktiengesellschaft | Device for evaluating the mixing of liquid anesthetic and a respiratory gas for patients |
US5038769A (en) * | 1983-06-29 | 1991-08-13 | Krauser Robert S | Method and apparatus for treating ailments |
US4653494A (en) * | 1985-12-20 | 1987-03-31 | Ruderian Max J | Nasal inhalation system |
US5404871A (en) | 1991-03-05 | 1995-04-11 | Aradigm | Delivery of aerosol medications for inspiration |
US5542410A (en) | 1991-03-05 | 1996-08-06 | Aradigm Corporation | Delivery of aeerosol medications for inspiration |
US5655516A (en) | 1991-03-05 | 1997-08-12 | Aradigm Corporation | Delivery of aerosol medications for inspiration |
US5497763A (en) | 1993-05-21 | 1996-03-12 | Aradigm Corporation | Disposable package for intrapulmonary delivery of aerosolized formulations |
US5544646A (en) | 1993-05-21 | 1996-08-13 | Aradigm Corporation | Systems for the intrapulmonary delivery of aerosolized aqueous formulations |
US5660166A (en) | 1993-05-21 | 1997-08-26 | Aradigm Corporation | Systems for the intrapulmonary delivery of aerosolized aqueous formulations |
US5709202A (en) | 1993-05-21 | 1998-01-20 | Aradigm Corporation | Intrapulmonary delivery of aerosolized formulations |
US5718222A (en) | 1993-05-21 | 1998-02-17 | Aradigm Corporation | Disposable package for use in aerosolized delivery of drugs |
Non-Patent Citations (1)
Title |
---|
See also references of EP1091778A4 * |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9211382B2 (en) | 2001-05-24 | 2015-12-15 | Alexza Pharmaceuticals, Inc. | Drug condensation aerosols and kits |
US9440034B2 (en) | 2001-05-24 | 2016-09-13 | Alexza Pharmaceuticals, Inc. | Drug condensation aerosols and kits |
US10350157B2 (en) | 2001-05-24 | 2019-07-16 | Alexza Pharmaceuticals, Inc. | Drug condensation aerosols and kits |
US8955512B2 (en) | 2001-06-05 | 2015-02-17 | Alexza Pharmaceuticals, Inc. | Method of forming an aerosol for inhalation delivery |
US9308208B2 (en) | 2001-06-05 | 2016-04-12 | Alexza Pharmaceuticals, Inc. | Aerosol generating method and device |
US9439907B2 (en) | 2001-06-05 | 2016-09-13 | Alexza Pharmaceutical, Inc. | Method of forming an aerosol for inhalation delivery |
US9687487B2 (en) | 2001-06-05 | 2017-06-27 | Alexza Pharmaceuticals, Inc. | Aerosol forming device for use in inhalation therapy |
US11065400B2 (en) | 2001-06-05 | 2021-07-20 | Alexza Pharmaceuticals, Inc. | Aerosol forming device for use in inhalation therapy |
US8991387B2 (en) | 2003-05-21 | 2015-03-31 | Alexza Pharmaceuticals, Inc. | Self-contained heating unit and drug-supply unit employing same |
US9370629B2 (en) | 2003-05-21 | 2016-06-21 | Alexza Pharmaceuticals, Inc. | Self-contained heating unit and drug-supply unit employing same |
EP1882487A1 (en) | 2006-07-24 | 2008-01-30 | Canon Kabushiki Kaisha | Inhaler |
US11642473B2 (en) | 2007-03-09 | 2023-05-09 | Alexza Pharmaceuticals, Inc. | Heating unit for use in a drug delivery device |
Also Published As
Publication number | Publication date |
---|---|
AU4846299A (en) | 2000-01-17 |
US6131570A (en) | 2000-10-17 |
US20040105665A1 (en) | 2004-06-03 |
EP1091778A1 (en) | 2001-04-18 |
US6629526B2 (en) | 2003-10-07 |
EP1091778A4 (en) | 2009-06-03 |
AU759358B2 (en) | 2003-04-10 |
US6845216B2 (en) | 2005-01-18 |
US6263872B1 (en) | 2001-07-24 |
JP2002519120A (en) | 2002-07-02 |
US20010032647A1 (en) | 2001-10-25 |
CA2335553A1 (en) | 2000-01-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6263872B1 (en) | Temperature controlling device for aerosol drug delivery | |
US7143766B2 (en) | Temperature controlling device for aerosol drug delivery | |
AU708269B2 (en) | Device for aerosolized delivery of peptide drugs | |
US7458373B2 (en) | Aerosol generator for drug formulation | |
US8408200B2 (en) | Flow resistance modulated aerosolized active agent delivery | |
US20030192540A1 (en) | Therapeutic dry powder preparation | |
JPH10509606A (en) | Production of aerosolized insulin preparations | |
US20100132699A1 (en) | Burst valve for aerosol device | |
TW200400064A (en) | Aerosol generator for drug formulation and methods of generating aerosol | |
AU2002326862A1 (en) | Temperature controlling device for aerosol drug delivery | |
TWI311061B (en) | Aerosol generator for drug formulation and method for generating an aerosol with the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 48462/99 Country of ref document: AU |
|
ENP | Entry into the national phase |
Ref document number: 2335553 Country of ref document: CA |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 2000 556828 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1999932072 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1999932072 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWG | Wipo information: grant in national office |
Ref document number: 48462/99 Country of ref document: AU |